The Gene to Antibody Company ™
Antibody discovery against any target
Genovac offers the world’s most advanced antibody discovery solutions. Our innovative immunization technologies combined with our advanced hybridoma and Berkeley Lights Beacon platform provides success against the most challenging targets. We partner with all leading transgenic animal companies and offer everything from cDNA synthesis to antibody sequencing.Discovery Technologies
WE DELIVER MORE HITS IN THE SHORTEST POSSIBLE TIME
Our technologies dramatically increase the speed, robustness and precision with which we discover and produce new antibodies. We’re committed to delivering high value antibodies against the most difficult targets to enable our clients programs and reduce development timelines.
Listen to our latest webinar:
On November 19 2020 Genovac took part in a webinar hosted by GEN. Panelists from Genovac presented case studies on how we overcome these antibody discovery and development challenges by leveraging Genovac’s core genetic immunization technology, and the Beacon optofluidic system, to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species. Listen here.